Beyond Pattern Recognition: TLR2 Promotes Chemotaxis, Cell Adhesion, and Migration in THP-1 Cells

Cells. 2023 May 19;12(10):1425. doi: 10.3390/cells12101425.

Abstract

The interaction between monocytes and endothelial cells in inflammation is central to chemoattraction, adhesion, and transendothelial migration. Key players, such as selectins and their ligands, integrins, and other adhesion molecules, and their functions in these processes are well studied. Toll-like receptor 2 (TLR2), expressed in monocytes, is critical for sensing invading pathogens and initiating a rapid and effective immune response. However, the extended role of TLR2 in monocyte adhesion and migration has only been partially elucidated. To address this question, we performed several functional cell-based assays using monocyte-like wild type (WT), TLR2 knock-out (KO), and TLR2 knock-in (KI) THP-1 cells. We found that TLR2 promotes the faster and stronger adhesion of monocytes to the endothelium and a more intense endothelial barrier disruption after endothelial activation. In addition, we performed quantitative mass spectrometry, STRING protein analysis, and RT-qPCR, which not only revealed the association of TLR2 with specific integrins but also uncovered novel proteins affected by TLR2. In conclusion, we show that unstimulated TLR2 influences cell adhesion, endothelial barrier disruption, migration, and actin polymerization.

Keywords: THP-1; Toll-like receptor 2; cell adhesion; cell migration; chemotaxis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion
  • Cell Movement
  • Chemotaxis*
  • Endothelial Cells / metabolism
  • Humans
  • Integrins
  • THP-1 Cells
  • Toll-Like Receptor 2* / metabolism

Substances

  • Integrins
  • Toll-Like Receptor 2
  • TLR2 protein, human

Grants and funding

This research was funded by the Lower Austrian FTI Program, grant number K3-F-744/005-2019. F.H. and B.N. are funded by the GFF NÖ by means of the Province of Lower Austria (Stiftungsprofessur ‘Clinical Proteomics Krems’) and the Austrian Research Promotion Agency (FFG) (COIN Development ‘ImmunoProteomics’).